Embed Size (px)
Citation preview
INTERNATIONALCONFERENCE ONCHALLENGES INCHALLENGES INDRUG DISCOVERYAND DELIVERYICCD3‐2017M h 2 4 2017
ORGANIZED BY:DepartmentofPharmacy,BirlaInstituteofTechnology&Science(BITS)‐Pilani,Pilani Campus,Vid Vih R j th 333031March2‐4,2017 Vidya Vihar,,Rajasthan333031
FUNDED AND SUPPORTED BY:ScienceandEngineeringResearchBoard(SERB)Dept.ofScienceandTechnology,Govt.ofIndia
CONFERENCE VENUEBITS‐Pilani Campus,Vidya Vihar,Pilani,RajasthanE‐mail : [email protected]‐pilani.ac.inPhone: +91‐1596‐51‐5206,+91‐1596‐51‐5226Website: http://discovery.bits‐pilani.ac.in/iccd3/index.html
INVITATIONDepartment of Pharmacy, BITS‐Pilani would like to invite you to theInternational Conference on Challenges in Drug Discovery and Delivery(ICCD3) b h ld B l I f T h l d S P l(ICCD3) to be held in Birla Institute of Technology and Science‐Pilani,Rajasthan, India in March 2‐4, 2017. The conference will have invitedlectures from eminent scientists in the field from around the globe. Further,during this three‐day event, the participants will have opportunities tomeet network colleagues and present their latest research findings as oralshort communications / posters. The future networking opportunities/ p g ppbetween the research groups will be also discussed.
THEME OF THE CONFERENCEDuring the past few years, pharmaceutical industry has evolved to be moreknowledge‐based and innovation driven industry. Drug discovery programhas gone through series of transformations from random screening toti l d d i Thi h h d id d b tt h f ttirational drug design. This change had provided better chances of getting
successful hits. However there is still an unmet need for the development ofnew therapies particularly for chronic diseases due to development ofresistance and failure of current therapies. This results in the lookout fornewer methods including in silico design, high throughput screening, etc.Due to the cost and time involved in the R&D, efforts have also beendirected from drug discovery to drug product development. Attempts arebeing made to improve the efficacy of the already known therapeuticmolecules by repackaging them into the novel delivery systems. Howeverthe academic research conducted in this arena still requires strong linkwith the industry and identification of challenges in their commercialdevelopment I d hi h d i ddevelopment. In order to achieve the desired
pharmaceutical product, an amalgamation ofvarious fields including synthetic and naturalproduct chemistry, pharmaceutical analysis,molecular biology, biotechnology,pharmacology and novel drug delivery isp gy g yrequired. This conference is an effort to bringtogether such diverse specialists to identifythe unmet needs of this multidisciplinary fieldand provide vision on future path.
Experts from international and national academic community as well asindustry will be invited to bridge the gap between industry and academiaindustry will be invited to bridge the gap between industry and academia.Knowledge seekers will get an opportunity to understand the importance oflatest pharmaceutical and biomedical research.
Authors are invited to submit their significant original and unpublishedcontributions on the topics listed below, but certainly not limited to:
C A d d
CALL FOR ABSTRACTS
o Computer Aided Drug Designo Combinatorial Chemistryo Phytopharmaceutical/Natural Product Chemistryo Pharmacology and Pharmaco‐therapeuticso Preclinical and Clinical studieso Proteomics and Bioinformaticso ADMET and PK/PDmodelingo Quality Assurance and Regulatory Affairso Pharmaceutical Analysiso Advanced Drug Delivery Systems (including Gene Delivery)o Pharmaceutical Nanotechnology (including Nanobiotechnology)o Herbal Drug Technology
I DIMPORTANT DATESLastdateforAbstractsubmission: January25th,2017
Notificationofacceptance: January30th,2017
Lastdateforregistration: January30th,2017
Conferencedates:March2‐4,2017
LastdateforsubmissionofabstractsisJanuary25,2017
1.Modeofsubmission:
GUIDELINES FOR ABSTRACT
Electronic:E‐mailas'MSword' [email protected]‐pilani.ac.in
2.FileFormat:Submit'MSword'filewithtables,photosandgraphsembeddedwithinthetextofdocument(Allinblackandwhiteonly).Margin: Topandbottom(1"),leftandright(01.25").AbstractTitle: Topofpaper,centered;Font: AllCapital,Bold,TimesNewRoman,size14.AuthorName(s): Lastnamefollowedbyinitials,presentingauthortobeunderlined.Font: TimesNewRoman,size12.Affiliation(s): Institutionaddress,Font: TimesNewRoman,size10.( ) , ,Emailofthepresentingauthoriscompulsory, Font: TimesNewRoman, size10.KeyWords: Notmorethan5words,TimesNewRoman,size10.BodyText: Singlecolumn,Font:TimesNewRoman,size12,linespacing1.Subheadings: Font:AllCapital,Bold,TimesNewRoman,size12.
3.AbstractContents:Titleofpaper,Authorsnames,Affiliations,Emailaddress,Keywords.Abstractshouldclearlyindicatetheobjective,methodologyandtheachievedresultsofthestudy.UseofGraphs,TablesandDrawingsisstronglyrecommended.
4.Abstractlength:NotmorethanonefullpageonstandardA4sizedpaperinclusiveofalltables,photosandgraphs.
NOTE :• Listofacceptedabstractswillbecommunicatedtotheauthoraswellas
displayedonthewebsite,latestby 30thJanuary2017.• Only one paper per presenting author will be accepted• Onlyonepaperperpresentingauthor willbeaccepted.• Innovativepaperswillbeselectedforawards.Preliminaryselectionforawardswouldbebasedontheabstracts.
The conference registration includes access to all the sessions, meals on allf d d f th b t t b kl t
REGISTRATION DETAILS
conference days and one copy of the abstract booklet.
Please mail the duly filled copy of the conference registration form(available at: http://discovery.bits‐pilani.ac.in/iccd3/registration.html )to : [email protected]‐pilani.ac.in.
The fee structure for registering in the conference:
Participants Amount
IndustryPersonnel 7000INR
AcademicFaculty/Scientist 5000INR
h h l / d
The fee structure for registering in the conference:
Ph.D Scholars/Students 3000INR
Foreign Delegates 150USD
Registrationfeeshouldbebanktransferredtothefollowingaccount.Pleaseemailthescreen‐shotorreceiptoftheaccounttransfer along with the registration form to :transferalongwiththeregistrationformto:[email protected]‐pilani.ac.in
Lastdateforregistration: January30th,2017
BeneficiaryName BirlaInstituteofTechnology&Science,Pilani
IFSC/RTGSCode ICIC0001538
AccountType SEVINGS
Bank ICICIBankLtd.
Branch Pilani
City Pilani
MICRNumber 333229175
SwiftCode ICICINBBNRI
BankAccountNumber 079901000123
KEY SPEAKERSChiefGuest:Dr.G.N.Singh,DrugsControllerGeneralofIndiaInternationalSpeakers:Dr.BruceA.Shapiro,NationalCancerInstitute,USA.Prof.LuigiAgrofoglio,CNRS,Universitéd'Orléans,France.Prof.Vinod Labhasetwar,LernerResearchInstitute,USA.Prof.RafaelBalana Fouce,UniversityofLeón,Spain.Prof.Mandip Sachdeva,FloridaAgriculturalandMechanicalUniversity,USA.Dr.Arvind Kinhikar,NovartisInstitutesforBioMedical Research,USA.Dr.MathiasViard,FrederickNationalLaboratoryforCancerResearch,USA.P f F Alh i U i ità di R R It lProf.FrancoAlhaique,Università di Roma,Roma,Italy.Prof.Shyh DarLi,UniversityofBritishColumbia,Canada.Dr.Anu Puri,NationalCancerInstitute,USA.Prof.Neetu Tyagi,UniversityofLouisville,Louisville.Dr.Lakshmi P.Kotra,UniversityofToronto,Canada.Dr.Shruti Agrawal,Bristol‐MyersSquibbCompany,Princeton,USA.Dr Arvind Kinhikar Novartis Institutes for BioMedical Research USADr.Arvind Kinhikar, NovartisInstitutesforBioMedical Research,USA.
NationalSpeakers:Prof.Devanand Shinde,ViceChancellor,Shivaji University,Kohlapur.Dr.Amulya K.Panda,NII,NewDelhi.Prof.Asit K.Chakraborty,NIPER,SASNagar,Punjab.Prof.Bhupinder SinghBhoop,UIPS,Panjab University,Chandigarh.Dr Anil N Gaikwad CDRI LucknowDr.AnilN.Gaikwad,CDRI,Lucknow.Dr.Sandeep Bharate,CSIR‐IIIMJammu.Dr.SanjayJachak,NIPER,SASNagar,Punjab.Dr.P.Chattopadhyay,DRL,DRDO,Tezpur.Prof.K.Ruckmani,AnnaUniversity,Chennai.Prof.S.K.Shrivastava,IIT‐BHU,Varanasi.Prof.Arvind K.Bansal,NIPER,SASNagar,Punjab.
f h bProf.Saranjit Singh,NIPER,SASNagar,Punjab.Dr.B.Dinesh Kumar,NationalInstituteofNutrition,HyderabadProf.Kulbhushan Tikoo,NIPER,SASNagar,PunjabProf.Shyam SunderSharma,NIPER,SASNagar,PunjabDr.Goutam Ghosh,PanaceaBiotec Ltd.Dr.Arshad Khuroo, SUNPharma.Dr.Arvind Saklani,SAMILabs,Bangalore.gDrAshish Rastogi, ExcelLifeSciencesPvt Ltd.,NewDelhi.Dr.RajKShirumalla,Diachi SankyoIndia.Dr.Chandrashekhar Patil,PanaceaBiotec.Dr.Chhanda Kapadia, Gattefossé IndiaPvt Ltd.Dr.G.V.R.Joseph,AYUSH.Dr.Vinod Nair,NectarLifesciences.Dr. Anurag Sood ZoetisDr.Anurag Sood,Zoetis.Dr.Saurabh Singh,NovartisHealthcarePrivateLimited,Hyderabad.Dr.Arun KumarPandey, Alkem LabsLtd‐ Mumbai.Dr.Hemant Bhutani , Bristol‐MyersSquibbIndiaPvt Limited,Bangalore,India.
BookingasperavailabilityLimited number of hostel accommodations are available @ 300 per person
ACCOMMODATION
Limited number of hostel accommodations are available @ 300 per personper day on first come‐first serve basis.Accommodation will be available at the Institute Guest House (VFAST) onfirst come‐first serve basis.
For detail, please visit: http://discovery.bits‐pilani.ac.in/iccd3/index.htmlEmail: [email protected]‐pilani.ac.inEmail: [email protected] pilani.ac.inPhone : +91‐1596‐51‐5847 (O), +91‐9950952634
HOW TO REACHPilani can be easily reached either by road or by rail. Nearest railwaystations are Chirawa on Western railway (~16 Km) and Loharu onstations are Chirawa on Western railway (~16 Km) and Loharu onNorthern railway (~24 Km). There are regular bus services from Delhi andJaipur to Pilani. By road, distance from Delhi is ‐200km and from Jaipur, ‐250km.
NEARBY PLACES TO VISIT
The Birla Institute of Technology and Science, Pilani known to many as
BITS Pilani, is an all‐India Institute for higher education. Founded in 1964
in collaboration with MIT, USA, it is one of the top most educational
Institute in India. The Department of Pharmacy at BITS Pilani is one of the
few early schools of Pharmacy in India Established in 1950 under the ablefew early schools of Pharmacy in India. Established in 1950 under the able
leadership of (Late) Prof. M. L. Schroff, Father of Pharmacy Education in
India. Currently the department offers Bachelor, Masters and Ph.D
programs in Pharmacy. Faculties of Department of Pharmacy are actively
involved in carrying out extra‐mural research projects funded by various
industries (Torrent, IPCA, Lubrizol, TTK LIG Ltd, SPIC, BASF, Etica
Clinpharma, Pvt, Ltd) and Government bodies (SERB, ICMR, UGC, DBT, DST,
CSIR ITRA)CSIR, ITRA).
Contact:Contact:DepartmentofPharmacy
BirlaInstituteofTechnology&Science(BITS),Pilani,Pilani CampusVidya Vihar,Pilani,Rajasthan333031E‐mail : [email protected]‐pilani.ac.in
Phone: +91‐1596‐51‐5206;+91‐1596‐51‐5226
